Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;118(3):371-5.
doi: 10.1046/j.1365-2249.1999.01054.x.

Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression

Affiliations

Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression

G Brusco et al. Clin Exp Immunol. 1999 Dec.

Abstract

This study was aimed at verifying whether tissue transglutaminase (tTG) is the sole autoantigen eliciting anti-endomysial antibodies in coeliac disease (CoD) and investigating tTG expression in normal and coeliac mucosa. Twelve anti-endomysial-positive coeliac sera and 12 anti-endomysial-negative control sera (10 microl, diluted 1:5-1:400 in PBS pH 7.3) were preincubated with 10, 20 or 50 microg guinea pig liver tTG at 4 degrees C overnight. Monkey oesophagus tissue slides were then tested with tTG-preincubated and non-preincubated sera to search for IgA anti-endomysial reactivity by indirect immunofluorescence. Moreover, six sections of monkey oesophagus were incubated with an anti-tTG mouse MoAb, six sections with an anti-cytokeratin mouse MoAb and six sections with only 3% bovine serum albumin. Finally, endoscopic duodenal biopsy sections obtained from 12 patients affected by untreated CoD, six patients affected by treated CoD and 10 biopsied controls were immunohistochemically stained with a peroxidase-conjugated anti-tTG MoAb. Our results show that (i) preincubation with tTG abolished endomysial immunofluorescence in most, but not in all, coeliac sera; (ii) the incubation of anti-tTG MoAb with sections of monkey oesophagus resulted in an immunofluorescence staining pattern similar but not identical to that of anti-endomysial-positive coeliac sera; (iii) although tTG expression was present at muscularis mucosae and pericryptal fibroblast in both normal and coeliac mucosa, it was slightly more marked and evident in the latter. Although our absorption experiment was performed with guinea pig liver tTG, we confirm that tTG is the predominant antigen of endomysial antibodies, but we speculate that, at least in some patients, it is not the only one.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Indirect immunofluorescence after the incubation of an anti-transglutaminase MoAb on monkey oesophagus: a staining pattern similar to that of coeliac endomysial antibodies is evident. (b) Indirect immunofluorescence after the incubation of coeliac serum on monkey oesophagus: the classical endomysial pattern is evident.
Fig. 2
Fig. 2
Immunohistochemistry of a duodenal biopsy specimen from an untreated coeliac patient stained with an anti-transglutaminase MoAb. Tissue transglutaminase prevailed at the level of muscularis mucosae and of pericryptal fibroblast.

Similar articles

Cited by

References

    1. Dieterich W, Ehnis T, Baur M, Donner P, Volta U, Riecken EO, Shuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801. - PubMed
    1. Brusco G, Izzi L, Corazza GR. Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol. 1998;30:496–7. - PubMed
    1. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115:1322–8. - PubMed
    1. Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillett H, Riecken EO, Shuppan D. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998;115:1317–21. - PubMed
    1. Molberg Ø, McAdam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognised by gut-derived T cells in celiac disease. Nat Med. 1998;4:713–7. - PubMed

Publication types

MeSH terms